Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Americium-241 is a synthetic radioactive isotope and a member of the actinide series, primarily known as an alpha-particle emitter with a physical half-life of approximately 432 years [1]. It is not a natural biological component and does not serve any physiological function; instead, it is classified as a hazardous internal contaminant [1, 3]. Upon entering the human body via inhalation, ingestion, or contaminated wounds, americium-241 ions (predominantly in the trivalent state) circulate in the blood and preferentially deposit in the liver and on bone surfaces [1, 4]. The localized emission of high-energy alpha particles causes significant ionizing radiation damage to nearby cells, leading to double-strand DNA breaks and increasing the long-term risk of bone cancer (osteosarcoma), liver disease, and hematopoietic dysfunction [1, 4]. Because americium-241 is a toxicant rather than a therapeutic target, medical intervention focuses on decorporation therapy using chelating agents such as Pentetate calcium trisodium (Ca-DTPA) and Pentetate zinc trisodium (Zn-DTPA) [2]. These drugs act as chelators, sequestering the americium ions from biological ligands and facilitating their renal clearance to reduce the radiation dose to tissues [2].
Chelation of the metal ion to form a stable, water-soluble complex that is excreted in the urine.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Americium-241 ion (Am-241).